US Patent 7438922 Human prostate cell lines in cancer treatment
Patent 7438922 was granted and assigned to Onyvax on October, 2008 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7438922 Human prostate cell lines in cancer treatment
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
